GreenLight Medicines is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a range of disease areas.
GreenLight Medicines develops plant-derived cannabinoid molecules from proprietary strains. The intellectual property portfolio is based on proprietary blends of cannabinoids, novel plant oil extraction processes and cannabis cultivation technologies (hardware and software).